Strategies for spinal cord protection during descending thoracic and thoracoabdominal aortic surgery: Up-to-date experimental and clinical results - A review

Scandinavian Cardiovascular Journal

Volumn 36, Issue 3, 2002, Pages 136-160

  Juvonen, Tatu ^a   Biancari, Fausto ^b   Rimpiläinen, Jussi ^b   Satta, Jari ^b   Rainio, Pekka ^b   Kiviluoma, Kai ^a  

^a UNIVERSITY OF OULU   (Finland)

^b Department of Cardio thoracic and Vascular Surgery ^*  (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; ADENOSINE; ADENOSINE A2 RECEPTOR AGONIST; ADENOVIRUS VECTOR; ALLOPURINOL; ATL 146 E; BETA GALACTOSIDASE; CALCIUM CHANNEL BLOCKING AGENT; DEFERIPRONE; DEFEROXAMINE; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GLUCOCORTICOID; HETASTARCH; ILOPROST; INSULIN; KETAMINE; MAGNESIUM SULFATE; MEMANTINE; METHYLPREDNISOLONE; OMEGA CONOTOXIN MVIIA; OXYGEN; PRASTERONE SULFATE; PROSTACYCLIN; PROSTAGLANDIN; PROSTAGLANDIN E1; RILUZOLE; SOMATOMEDIN C; SUPEROXIDE DISMUTASE; TETRACAINE; TIRILAZAD; UNCLASSIFIED DRUG;

ABDOMINAL ANGIOGRAPHY; ABDOMINAL AORTA; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA SURGERY; ARTERY PERFUSION; BLOOD VESSEL TRANSPLANTATION; BRADYCARDIA; CEREBROSPINAL FLUID DRAINAGE; CEREBROSPINAL FLUID PRESSURE; CONTROLLED STUDY; DOPPLER FLOWMETRY; DRUG MECHANISM; EVOKED CORTICAL RESPONSE; EVOKED MUSCLE RESPONSE; EVOKED SPINAL CORD RESPONSE; HUMAN; HYPOTENSION; INDUCED HYPOTHERMIA; NONHUMAN; OXYGEN TENSION; PARAPLEGIA; PATIENT MONITORING; PH ELECTRODE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REVIEW; SPINAL CORD BLOOD FLOW; SPINAL CORD ISCHEMIA; SURGICAL TECHNIQUE; THORACIC AORTA; THORAX SURGERY; VIRAL GENE DELIVERY SYSTEM;

EID: 0036290243     PISSN: 14017431     EISSN: None     Source Type: Journal    
DOI: 10.1080/cdv.36.3.136.160     Document Type: Review

References (199)

1. Thoracoabdominal aneurysm repair: A representative experience
2. Aneurysms of the descending thoracic aorta: Three hundred sixty-six consecutive cases resected without paraplegia
3. Spinal cord ischemic complications after thoracoabdominal aortic surgery
4. Experience with 1509 patients undergoing thoracoabdominal aortic operations
5. Surgical treatment of thoracoabdominal aortic aneurysm by simple crossclamping: Risk factors and late results
6. Arterial vascularization of the spinal cord. Recent studies of the anatomic substitution pathways
7. Does the Adamkiewicz artery originate from the large segmental arteries?
8. Vulnerability of great medullary artery
9. Angiography of the spinal cord
10. The anterior spinal artery: The main arterial supply of the human spinal cord. A preliminary anatomic study
11. The blood supply of the human spinal cord
12. The arterial blood supply of the human spinal cord
13. Vascular system of the human spinal cord
14. Circulation of the spinal cord and the effect of vascular occlusion
15. Feeder arteries, longitudinal arterial trunks and arterial anastomoses of the lower human spinal cord
16. Contribution l'étude de la sciatique paralysante
17. Ischemic myelopathy: A review of spinal vasculature and related clinical syndromes
18. Lumbosacral anterolateral spinal arteries and brief review of "accessory" longitudinal arteries of the spinal cord
19. Intimal musculature of the lower anterior spinal artery
20. Aspects of the spinal cord circulation as assessed by intratechal oxygen tension monitoring during various arterial interruptions in the pig
21. Looking for the artery of Adamkiewicz: A quest to minimize paraplegia after operations for aneurysms of the descending thoracic and thoracoabdominal aorta
22. Angiographic localization of spinal cord blood supply and its relationship to postoperative paraplegia
23. Prevention of paraplegia during thoracic aortic cross-clamping: Importance of patent internal mammary arteries
24. Influence of low proximal aortic pressure on spinal cord oxygenation in experimental thoracic aortic occlusion
25. Surgery of thoracoabdominal aneurysms
26. Spinal cord ischemia after ligation of both internal iliac arteries during radical cystoprostatectomy
27. Neurologic injury after endovascular stent-graft and bilateral internal iliac artery embolization for infrarenal abdominal aortic aneurysm
28. Clinical implications of internal iliac artery embolization in endovascular repair of aortoiliac aneurysms
29. Prevention of postoperative paraplegia after operation of descending thoracic and thoracoabdominal aneurysm repair
30. Hypothermic circulatory arrest for thoracic aneurysmectomy through left-side thoracotomy
31. The role of spinal angiography in operations of the thoracic aorta: Myth or reality?
32. Spinal cord infarction following vertebral angiography: Clinical and pathological findings
33. Preoperative demonstration of the Adamkiewicz artery by magnetic resonance angiography in patients with descending or thoracoabdominal aortic aneurysms
34. Thoracoabdominal or descending aortic aneurysm repair after preoperative demonstration of the Adamkiewicz artery by magnetic resonance angiography
35. Doppler ultrasonographic identification of the critical segmental artery for spinal cord protection
36. Measurement of spinal cord ischemia during operations upon the thoracic aorta: Initial clinical experience
37. Monitoring of somatosensory evoked potentials during surgical procedures on the thoracoabdominal aorta. I. Relationship of aortic cross-clamp duration, changes in somatosensory evoked potentials, and incidence of dysfunction
38. Somatosensory- and motor-evoked potentials in a rabbit model of spinal cord ischemia and reperfusion injury
39. The impact of distal aortic perfusion and somatosensory evoked potential monitoring on prevention of paraplegia after aortic aneurysm operation
40. Use of somatosensory evoked potentials for thoracic and thoracoabdominal aortic resections
41. Prevention of paraplegia in pigs by selective segmental artery perfusion during aortic cross-clamping
42. The risk of ischemic spinal cord injury in patients undergoing graft replacement for thoracoabdominal aortic aneurysms
43. Prevention and detection of spinal cord injury during thoracic and thoracoabdominal aortic repairs
44. Clinical application of evoked spinal cord potentials elicited by direct stimulation of the cord during temporary occlusion of the thoracic aorta
45. Monitoring for spinal cord ischemia by use of the evoked spinal cord potentials during aortic aneurysm surgery
46. Experimental study of the protection of ischemic preconditioning to spinal cord ischemia
47. Monitoring of evoked potentials during spinal cord ischemia: Experimental evaluation in a rabbit model
48. Motor evoked potentials in the dog: Effects of global ischemia on spinal cord and peripheral nerves signals
49. Direct noninvasive monitoring of spinal cord motor function during thoracic occlusion: Use of motor evoked potentials
50. Correlation of motor-evoked potential response to ischemic spinal cord damage
51. The relationship between evoked potentials and measurements of S-100 protein in cerebrospinal fluid during and after thoracoabdominal aortic aneurysm surgery
52. Intraoperative monitoring of tibialis anterior muscle motor evoked responses to transcranial electrical stimulation during partial neuromuscular blockade
53. The effect of nitrous oxide on transcranial magnetic-induced electromyographic responses in the monkey
54. Effects of propofol, etomidate, midazolam and fentanyl on motor evoked responses to transcranial electrical or magnetic stimulation in humans
55. Low concentrations of isofluorane abolish motor evoked responses to transcranial electrical stimulation during nitrous oxide/opioid anesthesia in humans
56. Within-patient variability of myogenic motor-evoked potentials to multipulse transcranial electrical stimulation during two levels of partial neuromuscular blockade in aortic surgery
57. The influence of regional spinal cord hypothermia on transcranial myogenic motor-evoked potential monitoring and the efficacy of spinal cord ischemia
58. Evoked potential monitoring to assess spinal cord ischemia during TAAA repair
59. Identification of the critical spinal arteries with F wave-polysynaptic response complex monitoring: An experimental study
60. Monitoring of intrathecal oxygen tension during experimental aortic occlusion predicts ultrastructural changes in the spinal cord
61. Increased FiO2 improves intrathecal oxygenation during thoracic aortic cross-clamping in pigs
62. Influence of preservation or perfusion of intraoperatively identified spinal cord blood supply on spinal motor evoked potentials and paraplegia after aortic surgery
63. Intraoperative identification of spinal cord blood supply during repairs of descending aorta and thoracoabdominal aorta
64. Preliminary report of localization of spinal cord blood supply by hydrogen during aortic operations
65. Quick, simple clamping technique in descending thoracic aortic aneurysm repair
66. Evolution of surgical techniques for aneurysms of the descending thoracic aorta: Twenty-nine years experience with 659 patients
67. Impact of left heart bypass on the results of thoracoabdominal aortic aneurysm repair
68. Commentary
69. The mechanism of paraplegia after temporary aortic occlusion and its relationship to spinal fluid pressure
70. New and simple method of preventing spinal cord damage following temporary occlusion of the thoracic aorta by draining the cerebrospinal fluid
71. Cross-clamping the thoracic aorta. Effect on intracranial pressure
72. Mechanism of increased cerebrospinal fluid pressure with thoracic aortic occlusion
73. Cerebral haemodynamics during thoracic and thoracoabdominal aortic aneurysm repair
74. Alterations in intracranial volume following cross-clamping of the descending thoracic aorta in pigs: An experimental study using MRI
75. Blood flow and vascular permeability during motor dysfunction in a rabbit model of spinal cord ischemia
76. Effects of thoracic aortic occlusion and cerebrospinal fluid drainage on regional spinal cord blood flow in dogs: Correlation with neurologic outcome
77. Epidural cooling for spinal cord protection during thoracoabdominal aneurysm repair: A five-year experience
78. Protecting the ischemic spinal cord during aortic clamping: The influence of selective hypothermia and spinal cord perfusion pressure
79. Spinal cord injury in experimental thoracic aortic occlusion: Investigation of combined methods of protection
80. Paraplegia after thoracic aortic occlusion: Influence of cerebrospinal fluid drainage
81. Combined use of cerebral spinal fluid drainage and naloxone reduce the risk of paraplegia in thoracoabdominal aneurysm repair
82. A prospective randomized study of cerebrospinal fluid drainage to prevent paraplegia after high-risk surgery on the thoracoabdominal aorta
83. Effects of cerebrospinal fluid drainage in patients undergoing thoracic and thoracoabdominal aortic surgery
84. Effect of sodium nitroprusside on paraplegia during cross-clamping of the thoracic aorta
85. Sodium nitroprusside decreases spinal cord perfusion pressure during descending thoracic aortic cross-clamping in the dog
86. Trimethaphan versus sodium nitroprusside for the control of proximal hypertension during thoracic aortic cross-clamping: The effects on spinal cord ischemia
87. Reversal of twice-delayed neurologic deficits with cerebrospinal fluid drainage after thoracoabdominal aneurysm repair: A case report and plea for a national database collection
88. Reversal of delayed-onset paraplegia after thoracic aortic surgery with cerebrospinal fluid drainage
89. Effect of altering cerebrospinal fluid pressure on spinal cord blood flow
90. Spinal cord protection in the absence of collateral circulation: Metaanalysis of mortality and paraplegia
91. Risk of replacement of descending aorta with a standardized left heart bypass technique
92. Initial experience with the Nikkiso centrifugal pump during thoracoabdominal aortic aneurysm repair
93. Thoracoabdominal aortic aneurysms: Experience with 372 patients
94. Spinal cord protection in descending thoracic and thoracoabdominal aortic repair
95. Protection of the spinal cord during surgery of thoraco-abdominal aortic aneurysms
96. Safety and efficacy of hypothermic cardiopulmonary bypass and circulatory arrest for operations on the descending thoracic and thoracoabdominal aorta
97. Thoracic and thoracoabdominal aneurysm repair under deep hypothermia using subclavian arterial perfusion
98. Experimental and clinical assessment of the adequacy of partial bypass in maintenance of spinal cord blood flow during operations on the thoracic aorta
99. Distal circulatory support for thoracic aortic operation: Effects on intracranial pressure
100. Predictive factors for acute renal failure in thoracic and thoracoabdominal aortic aneurysm surgery
101. Management of thoracoabdominal aortic aneurysms
102. Preservation of intercostal arteries during thoracoabdominal aortic aneurysm surgery: A retrospective study
103. Discussion following the article by Ross SD, et al
104. Brain protection during aortic arch surgery
105. Cerebral metabolic suppression during hypothermic circulatory arrest in humans
106. Refrigeration in experimental surgery of the aorta
107. Hypothermia in the surgical treatment of aortic aneurysms
108. Coarctation of the aorta, experimental studies regarding its correction
109. The use of hypothermia in the prevention of paraplegia following temporary aortic occlusion: Experimental observations
110. The effect of profound levels of hypothermia (below 14 degrees C) on canine cerebral metabolism
111. Effect of mild hypothermia on ischemia-induced release of neurotransmitters and free fatty acids in rat brain
112. Mild and moderate hypothermia provide better protection than a burst-suppression dose of thiopental against spinal cord injury in rabbits
113. Thoracic and thoracoabdominal aortic aneurysm repair using cardiopulmonary bypass, profound hypothermia, and circulatory arrest via left side of the chest incision
114. Neuronal cell death in the ischemic spinal cord: The effect of methylprednisolone
115. Outcome of thoracoabdominal aortic operations using deep hypothermia and distal exsanguination
116. The effects of moderate hypothermia and intratechal tetracaine on glutamate concentrations of intratechal dialysate and neurologic and histopathologic outcome in transient spinal cord ischemia in rabbits
117. Profound systemic hypothermia inhibits the release of neurotransmitter amino acids in spinal cord ischemia
118. Moderate hypothermia, with partial bypass and segmental sequential repair for thoracoabdominal aortic aneurysm
119. Active cooling during open repair of thoraco-abdominal aortic aneurysms improves outcome
120. Mild perioperative hypothermia and the risk of wound infection
121. Cooling for acute ischemic brain damage (cool aid): An open pilot study of induced hypothermia in acute ischemic stroke
122. Spinal cord ischemia and reperfusion metabolism: The effect of hypothermia
123. Protection against ischemic spinal cord injury: One-shot perfusion cooling and percutaneous topical cooling
124. Panmyelic epidural cooling protects against ischemic spinal cord damage
125. Protection from post ischemic spinal cord injury by perfusion cooling of the epidural space
126. Establishment of a local cooling model against spinal cord ischemia representing prolonged induction of heat shock protein
127. Spinal cord protection during aortic cross clamping: Retrograde venous spinal cord perfusion, distal aortic perfusion, cerebrospinal fluid drainage
128. Retrograde venous perfusion with hypothermic saline and adenosine for protection of the ischemic spinal cord
129. Spinal cord protection during aortic cross-clamping using retrograde venous perfusion
130. O2 monitoring for spinal cord protection
131. Selective perfusion of segmental arteries in patients undergoing thoracoabdominal aortic surgery
132. Intermittent retrograde cerebral perfusion during prolonged period of hypothermic circulatory arrest: A study in a chronic porcine model
133. Is the maintained cranial hypothermia the only factor leading to improved outcome following retrograde cerebral perfusion? An experimental study using a chronic porcine model
134. Retrograde cerebral perfusion provides negligible flow through brain capillaries in the pig
135. Retrograde perfusion of the spinal cord during aortic crossclamping: Initial observations in the swine model
136. Retrograde perfusion with a sodium channel antagonist provides spinal cord protection
137. "Ischemic tolerance" phenomenon detected in various brain regions
138. Ischemic tolerance in hippocampal CA1 neurons studied using contralateral controls
139. Induction of the HSP110/105 family in the rat hippocampus in cerebral ischemia and ischemic tolerance
140. Effect of spinal cord preconditioning on paraplegia during cross-clamping of the thoracic aorta
141. Ischemic preconditioning protects against paraplegia after transient aortic occlusion in the rat
142. Enhancement of heat shock protein expression after transient ischemia in the preconditioned spinal cord of rabbits
143. Ischemic preconditioning reduces neurologic injury in a rat model of spinal cord ischemia
144. Tolerization against loss of neuronal function after ischemia-reperfusion injury
145. Excessive release of [3H]noradrenaline and glutamate in response to stimulation of ischemic conditions in rat spinal cord slice preparation: Effect of NMDA and AMPA receptor antagonists
146. Effect of ischemic pretreatment on heat shock protein 72, neurologic outcome, and histopathologic outcome in a rabbit model of spinal cord ischemia
147. Efficacious experimental stroke treatment with high-dose methylprednisolone
148. Neuroprotective actions of glucocorticoid and nonglucocorticoid steroids in acute neuronal injury
149. Preoperative high dose methlyprednisolone attenuates the cerebral response to deep hypothermic circulatory arrest
150. Prevention of ischemic spinal cord injury following aortic cross-clamping: Use of corticosteroids
151. An intraaortic solution trial to prevent spinal cord injury in a rabbit model
152. a receptors
153. Additive effect of allopurinol and deferoxamine in the prevention of spinal cord injury caused by aortic crossclamping
154. Cross-clamping of the thoracic aorta. Influence of aortic shunts, laminectomy, papaverine, calcium channel blocker, allopurinol, and superoxide dismutase on spinal cord blood flow and paraplegia in baboons
155. Effects of deferoxamine, a chelator of free iron, on NA(+), K(+)-ATPase activity of cortical brain cell membrane during early reperfusion after hypoxia-ischemia in newborn lambs
156. Deferoxamine reduces early metabolic failure associated with severe cerebral ischemic acidosis in dogs
157. Preliminary results of deferoxamine and L1 treatment of spinal cord ischemia
158. Insulin-like growth factor 1 prevents neuronal cell death and paraplegia in the rabbit model of spinal cord ischemia
159. Infrarenal aortic occlusion in the rabbit to assess the effect of flunarizine in the prevention of ischemic spinal cord injury
160. The effects of nimodipine on ischemic injury of the spinal cord during thoracic aortic cross-clamping
161. Effects of flunarizine on neurological recovery and spinal cord blood flow in experimental spinal cord ischemia in rabbits
162. Spinal cord protection with intravenous nimodipine. A functional and morphologic evaluation
163. The neuroprotective effects of intratechal administration of the selective N-type calcium channel blocker ziconotide in a rat model of spinal ischemia
164. SNX-111, a novel, presynaptic N-type calcium channel antagonist, is neuroprotective against focal cerebral ischemia in rabbits
165. A selective N-type calcium channel antagonist protects against neuronal loss after global cerebral ischemia
166. Memantine reduces functional and morphological consequences induced by global ischemia in rats
167. Reduction of edema and infarction by memantine and MK-801 after focal ischaemia and reperfusion in rat
168. The N-methyl-D-aspartate antagonist memantine has no neuroprotective effect during hypothermic circulatory arrest: A study in the chronic porcine model
169. No protective effect of the NMDA antagonist memantine in experimental spinal cord injuries
170. Menantine for prevention of spinal cord injury in a rabbit model
171. Prevention of ischemic spinal cord injury: Comparative effects of magnesium sulfate and riluzole
172. Neuroprotective effects of riluzole and ketamine during transient spinal cord ischemia in the rabbit
173. + channel stimulated by arachidonic acid and polyunsaturated fatty acids
174. Dose optimization of intravenous magnesium sulfate after acute stroke
175. Effect of profound hypermagnesemia on spinal cord glucose utilization in rats
176. NMDA receptor blockade and spinal cord ischemia due to aortic crossclamping in the rat model
177. Protection against experimental ischemic spinal cord injury
178. Intratechal magnesium sulfate protects the spinal cord from ischemic injury during thoracic aortic cross-clamping
179. Neuroprotective effect of magnesium on lipid peroxidation and axonal function after experimental spinal cord injury
180. Adenosine modulates N-methyl-D-aspartate-stimulated hippocampal nitric oxide production in vivo
181. Complete prevention of postischemic spinal cord injury by means of regional infusion with hypothermic saline and adenosine
182. Regional adenosine attenuates postischemic spinal cord injury
183. An adenosine A2A agonist, ATL-146e, reduces paralysis and apoptosis during rabbit spinal cord reperfusion
184. 1
185. Does prostaglandin E1 and superoxide dismutase prevent ischaemic spinal cord injury after thoracic aortic cross-clamping?
186. Iloprost protects the spinal cord during aortic cross-clamping in a canine model
187. Spinal cord protection with the use of prostacyclin during aortic occlusion
188. Protein C anticoagulant pathway and its role in controlling microvascular thrombosis and inflammation
189. Activated protein C and inflammation in human myocardium after heart surgery
190. Anti-inflammatory, antithrombotic, and neuroprotective effects of activated protein C in a murine model of focal ischemic stroke
191. Brain injury and cerebrovascular fibrin deposition correlate with reduced antithrombotic brain capillary functions in a hypertensive stroke model
192. Activated protein C reduces the ischemia/reperfusion-induced spinal cord injury in rats by inhibiting neutrophil activation
193. Macromolecules reduce abnormal microvascular permeability in rat limb ischemia-reperfusion injury
194. Attenuation of microvascular permeability dysfunction in postischemic striated muscle by hydroxyethyl starch
195. Hydroxyethyl starch reduces leukocyte adherence and vascular injury in the newborn pig cerebral circulation after asphyxia
196. Medium molecular weight pentastarch reduces reperfusion injury by decreasing capillary leak in a model of spinal cord ischemia
197. Adenovirus-mediated glial cell line-derived neurotrophic factor gene delivery reduces motor neuron injury after transient spinal cord ischemia in rabbits
198. Neuroprotection mediated by glial cell line-derived neurotrophic factor: Involvement of a reduction of NMDA-induced calcium influx by the mitogen-activated protein kinase pathway
199. Epidural regional hypothermia for prevention of paraplegia after aortic occlusion: Experimental evaluation in a rabbit model